September 13, 2026, Peptides Now! - Khavinson's Blend - Deep Dive with Alex and Jessica copertina

September 13, 2026, Peptides Now! - Khavinson's Blend - Deep Dive with Alex and Jessica

September 13, 2026, Peptides Now! - Khavinson's Blend - Deep Dive with Alex and Jessica

Ascolta gratuitamente

Vedi i dettagli del titolo

Offerte di stagione | 0,99 €/mese per i primi 3 mesi

A seguire 9,99 €/mese – si applicano condizioni. Puoi disdire mensilmente.

Title: September 13, 2026, Peptides Now! - Khavinson's Blend - Deep Dive with Alex and Jessica

Keep the momentum at: https://www.v2u.us/subscribe

If you’ve found this episode informative, insightful or beneficial, don’t forget to like and share with someone who may also benefit.

Primary Keyword Cluster: Khavinson peptides, Epitalon longevity, FDA peptide regulations 2026, anti aging peptide therapy, cellular signaling

Description: Join hosts Alex and Jessica for an in-depth deep dive into Khavinson peptide bioregulators and the evolving regulatory landscape of cellular therapeutics in 2026. This episode explores the 12 hallmarks of aging, direct versus indirect energy peptides, and the controversial July 2026 FDA advisory committee review of Epitalon. Discover the rigorous science, safety concerns, and clinical realities driving modern longevity medicine.

• Decoding Cellular Text Messages: Explore how short-chain peptides act as targeted chemical commands addressing specific root mechanisms within the expanded 12 hallmarks of aging framework.

• Direct vs Indirect Energy Peptides: Examine the critical distinction between direct mitochondrial ATP enhancers like SS-31 Elamipretide and indirect metabolic secretagogues like Sermorelin and BPC-157.

• Khavinson Epitalon and FDA Regulations: Unpack the mechanics of Epitalon AEDG tetrapeptide, the 7-5 FDA advisory committee recommendation for compounding, and vital safety considerations between free base and acetate salt forms.

Timestamps:
• 0:00 – Introduction to Peptide Cellular Commands
• 2:45 – The 12 Hallmarks of Aging Framework
• 5:30 – Direct vs Indirect Energy Peptides
• 9:15 – SS-31 Elamipretide and Mitochondrial Approval
• 12:40 – Khavinson Peptides and Epitalon AEDG Mechanics
• 16:10 – The July 2026 FDA PCAC Advisory Committee Vote
• 19:25 – Free Base vs Acetate Salt Formulations
• 21:50 – Stacking Protocols, COAs, and Final Takeaways

Don't miss our next episode, where we'll continue to unravel the latest in AI innovation and market trends.

Tags and Keywords: #peptides, #khavinson, #epitalon, #longevity, #antiaging, #fdaregulations, #bioregulators

adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione